Dr. Cameron Crandall, MD

Claim this profile

University of New Mexico Hospital

Studies Opioid Use Disorder
Studies Drug Overdose
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of New Mexico Hospital

Clinical Trials Cameron Crandall, MD is currently running

Image of trial facility.

Buprenorphine

for Opioid Use Disorder

This study will (1) recruit, train and provide resources to approximately 30 Emergency Department (ED) sites throughout the U.S. using implementation facilitation strategies to provide ED-initiated buprenorphine (BUP) for patients presenting with opioid use disorder (OUD) who are not receiving medications for opioid use disorder (MOUD). Once implementation is adequately achieved, the sites will (2) conduct a randomized controlled trial (RCT) to compare the effectiveness of sublingual buprenorphine (SL-BUP) versus extended-release buprenorphine (XR-BUP) on ED patients' engagement in formal addiction treatment 7-days after their ED visit. In addition, in an ancillary component of the study, the investigators will (3) assess the use of XR-BUP in ED patients with Clinical Opioid Withdrawal Scale (COWS) scores \< 8 in a case series to potentially expand the eligibility of patients in the larger RCT to those presenting with little to no opioid withdrawal symptoms. Finally, the investigators will (4) develop and validate ED electronic health record (EHR) opioid-related phenotypes, both of which will inform the main RCT.
Recruiting3 awards Phase 218 criteria

More about Cameron Crandall, MD

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Cameron Crandall, MD has experience with
  • Buprenorphine Sublingual Product
  • CAM2038
  • IXT-m200
Breakdown of trials Cameron Crandall, MD has run
Opioid Use Disorder
Drug Overdose
Methamphetamine Intoxication

Other Doctors you might be interested in

Michel Torbey, MDUniversity of New Mexico Health Sciences Center
Tarun GirotraUniversity of New Mexico Hospital
Huy Tran, MDUniversity of New Mexico Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cameron Crandall, MD specialize in?
Cameron Crandall, MD focuses on Opioid Use Disorder and Drug Overdose. In particular, much of their work with Opioid Use Disorder has involved treating patients, or patients who are undergoing treatment.
Is Cameron Crandall, MD currently recruiting for clinical trials?
Yes, Cameron Crandall, MD is currently recruiting for 1 clinical trial in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Cameron Crandall, MD has studied deeply?
Yes, Cameron Crandall, MD has studied treatments such as Buprenorphine Sublingual Product, CAM2038, IXT-m200.
What is the best way to schedule an appointment with Cameron Crandall, MD?
Apply for one of the trials that Cameron Crandall, MD is conducting.
What is the office address of Cameron Crandall, MD?
The office of Cameron Crandall, MD is located at: University of New Mexico Hospital, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top